NLS Pharmaceutics Ltd. (NASDAQ: NLSP), a Swiss clinical-stage biopharmaceutical company focused on developing innovative ...

Recent selloffs create compelling entry points into these ultrahigh-growth stocks. When markets get jittery, high-growth ...

Ocugen has announced the US Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) amendment to ...

Leavenworth, Kansas, occupies a mythic space in American crime, its name alone evoking a short hand for serving hard time.

This biotech giant has been given a boost in the United States. The post CSL shares push higher on US FDA approval appeared ...

Two existing medications—one used for smoking cessation and the other for depression—appear to work effectively together in ...

LENZ Therapeutics is a late-stage vision therapy company with bullish analyst backing and strong cash reserves. Read why LENZ ...

Supernus to acquire Sage Therapeutics for $795 million, gaining Zurzuvae and aiming for $200 million in annual cost synergies by expanding its CNS portfolio.

HIV response. Experts are suggesting a projected 24% decrease in HIV funding over the next year in the context of reductions ...

We have recently begun acquiring a new position in Novo Nordisk. Click here for our investment thesis on NVO stock.